Thanks ljames.Another 6 million shares and the whole authorized issued will turn.Probably less out though.Love the rev projections.Bob

ljames,who you using for pink sheet level 2.Thanks

Thanks Art.The revenues as compared to price and shares authorized is really amazing.Nice find

Thanks Art bcit great value gone unnoticed until today.Bcit board:http://www.investorshub.com/boards/board.asp?board_id=3879

Thanks Rig eom.

OT:Rig as you know I an a holder of bb companies waiting for the value to rise to the top.Their was many doubters on cbyi at .015-.02.Still holding a boatload from those levels.The company had a transformation into Luxury real estate developments(short description).I am a bottom picker and would like your opinion here as well as gpxm.My opinion on cbyi is its a gem in the rough waiting to be born.Gpxm am still hashing things out.Watching another transformation supr.As you can see I like assets being built no matter how long it takes.Bob

Thanks jwr and doc.Any pertinent info you can give me please e mail me at : tropicshades@aol.com Thanks Bob

Took a starter position today.Only 10k.Will continue to dd and add as need be.Looks like a similar type almi investment.Just have to get the MO out of the ground.Plus Gold.Thanks for the input guys.patience

Thanks Doc.Will be back to you after I do some dd next few days.Take care Bob

OT:Brook will keep on watch and do some dd next few days as time provides.Thanks Bob

Thanks Rig eom.

OT:Rig hows it going?Been busy with my business and not doing much trading till fall,more of a accumulate stocks I like looking out 6-12 months mode right now.Have been accmulating cbyi since below .02.Hit.08 and now consolidating.I have a question.Did you do the dd on gpxm?Looks pretty interesting.Let me know what you think.Thanks Bob

Gooddoc,doing some dd here.Interesting company.I entered almi at these levels .14-.15 and held over 1.00.Still think almi sees 2.00-3.00 and keep it on watch.The uses for molybdenum are interesting.If you have time could you give me a brief 6-12 month outlook.Thanks Bob http://www.webelements.com/webelements/elements/text/Mo/uses.html

Dee/subtle cbyi:Form 8-K for CAL BAY INTERNATIONAL INC


--------------------------------------------------------------------------------

1-Apr-2005

Other Events



Item 8.01: Other Events
Cal Bay announced today that it has initiated a stock buy back program for shares of its common stock. Cal Bay will purchase, up to $100,000 of its stock on the open market. The buy back program will commence immediately and terminate when the designated funds have been exhausted. Cal Bay intends to comply with all appropriate regulations including Rule 10b-18 under the Securities Exchange Act of 1934. Repurchased shares will be cancelled and returned to the authorized but unissued stock of Cal Bay.

Cal Bay will disclose in its periodic reports to be filed with the Securities and Exchange Commission, the number of shares purchased, the average price paid per share and the approximate dollar value of shares that may yet be purchased under this stock buy back program.

OXPS

Xoma watch:

XOMA Awarded $15 Million Contract from NIAID to Help Fight Bioterrorism
Thursday March 10, 5:44 pm ET
XOMA to Develop Three Anti-Botulinum Neurotoxin Monoclonal Antibodies


BERKELEY, Calif.--(BUSINESS WIRE)--March 10, 2005--XOMA Ltd. (Nasdaq:XOMA - News) today announced that it was awarded a $15 million contract from the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH), to produce three botulinum neurotoxin monoclonal antibodies designed to protect U.S. citizens against the harmful effects of biological agents used in bioterrorism.
ADVERTISEMENT


Under the 18-month contract, XOMA will develop monoclonal antibody therapeutics using proprietary antibody expression systems to produce anti-type A-botulinum neurotoxin monoclonal antibodies including a Master Cell Bank (MCB), Manufacturer's Working Cell Bank (MWCB) and other designated deliverables. The antibodies will be produced under Good Manufacturing Practices (cGMP) at XOMA's manufacturing facility. This project will be 100% funded with Federal funds from NIAID under Contract No. HHSN266200500004C. SRI International, an independent, nonprofit research institute based in Menlo Park, CA, will be a subcontractor under this contract and will develop potency assays to support antibody characterization.

"Numerous events in the United States over the past few years serve as a stark reminder that the use of biological agents remains a real threat," said John L. Castello, president, chairman and CEO of XOMA. "As an industry leader in developing monoclonal antibodies, XOMA is committed to working with the U.S. government to develop new therapies to counter these biological threats."

"We have previously stated that an important part of our strategy for achieving profitability is increased utilization of our process development and manufacturing assets," continued Castello. "This contract with NIAID is an important step forward in achieving this objective."

About Botulism Neurotoxin (BoNT)

With the recent deliberate exposure of postal workers, other government employees, and the American public to Bacillus anthracis spores, there is an urgent need to devise effective measures to protect U.S. citizens from the harmful effects of biological agents used as instruments of terror. Botulinum neurotoxins are one of these biological threats and new vaccines, therapies and diagnostics are needed to counter the potential terrorist use of these toxins.

About NIAID

NIAID is a component of the National Institutes of Health, an agency of the U.S. Department of Health and Human Services. NIAID supports basic and applied research to prevent, diagnose and treat infectious diseases such as HIV/AIDS and other sexually transmitted infections, influenza, tuberculosis, malaria and illness from potential agents of bioterrorism. NIAID also supports research on transplantation and immune-related illnesses, including autoimmune disorders, asthma and allergies. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov.

About SRI

Silicon Valley-based SRI International (www.sri.com) is one of the world's leading independent research and technology development organizations. Founded as Stanford Research Institute in 1946, SRI has been meeting the strategic needs of clients for almost 60 years. The nonprofit research institute performs client-sponsored research and development for government agencies, commercial businesses and nonprofit foundations. SRI's Biosciences Division works with government agencies and commercial pharmaceutical and biotechnology companies to provide a broad range of preclinical drug discovery and development services, including medicinal chemistry, custom synthesis, regulatory support, efficacy and safety evaluations, pharmacokinetics and metabolism studies, analytical chemistry and formulation design in production in GLP and cGMP environments. The division specializes in cancer, infectious disease and neurobiological research.

About XOMA

XOMA develops and commercializes antibody and other protein-based biopharmaceuticals for cancer, immune disorders and infectious diseases. The company pipeline includes products from collaborative product development programs with Chiron Corporation, Millennium Pharmaceuticals, Inc., and Aphton Corporation. For more information about XOMA's product pipeline and antibody product development capabilities and technologies, please visit XOMA's website at http://www.xoma.com/.

Certain statements contained herein concerning current collaborations and product development or that otherwise relate to future periods, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on assumptions that may not prove accurate. Actual results could differ materially from those anticipated due to certain risks inherent in the biotechnology industry and for companies engaged in the development of new products in a regulated market. These risks, including those related to the results of pre-clinical testing, the timing or results of pending and future clinical trials (including the design and progress of clinical trials; safety and efficacy of the products being tested; action, inaction or delay by the FDA, European or other regulators or their advisory bodies; and analysis or interpretation by, or submission to, these entities or others of scientific data), changes in the status of the existing collaborative relationships, the ability of collaborators and other partners to meet their obligations, market demand for products, scale up and marketing capabilities, competition, uncertainties regarding the status of biotechnology patents, uncertainties as to the cost of protecting intellectual property and risks associated with XOMA's status as a Bermuda company, are described in more detail in the Company's most recent annual report on Form 10-K and in other SEC filings.



--------------------------------------------------------------------------------
Contact:
XOMA Ltd.
Deb McManus, 510-204-7240 (Media Relations)
or
Kureczka/Martin Associates
Ellen M. Martin, 510-832-2044 (Investor Relations)
or
SRI International
Ellie Javadi, 650-859-4874 (Media Relations)



--------------------------------------------------------------------------------

Dee,whats up?Been busy lately.Hope all is well.Yes any where from .025-.035 great entry with cbyi.Later friend

Tea should have been more specific.Does it show outstanding/authorized shares?

Thanks tea,appreciate it much.Where did you find it and what is it showing.Thanks again Bob

Help I am trying to find a symbol for atlantis holding corp.It is the new formation of old cal bay business structure.Supposedly got nasd approval to trade on pink sheets.Anyone know where to look,it would not be trading yet but would have nasd approval.Thanks

Hey dee,whats the deal with xlpi?Is it a technical trade or fundamental position?Thanks Bob

Interesting look at biph:http://www.investorshub.com/boards/read_msg.asp?message_id=5429537

BIPH starter

Hope all goes well dee.Family much more important than money.Later

Dee or anyone with imput.What do you guys think of the SHO short reporting rule?What effect do you think it has?Whats your general take on it?Thanks Bob http://www.investigatethesec.com/

Dee,do you know who clears through schwabb.Everytime volume slows on cbyi they camp out on ask.Thanks

I missed that.That was the flush out before yesterdays run.I should have had a standing order in.Hardly anyone got any under .02 on that dip.Want to sell them.What are your charts telling you as far as possible pullback?Thanks

Problem for traders,not if longterm holder.

Dee,the problem was getting shares.It took me weeks to get over 100k in the .016-.017 range.Most of the volume during last 2 weeks has been .025-.04.

Yea I know dee cbyi.Thats why I have this as a long term play.MM's have never given the 1-2 day traders a chance for quick buck unless you time it perfectly.I have followed and bought for months on every dip.Looking for another 100k.Hopefully in the mid .02 range.

Dee,entered posod Monday in 1.20's.Could be low float runner.Based on chart 2.00-2.20 seems reasonable at very least.Also twr for a bankruptcy bounce play.Halted now.

Thanks Dee,Love the formation back to sept.

Dee,what a rollercoaster cbyi back up today.Needs to break .04 with volume.Last two weeks over 3mill traded mainly buys.before today around 300k.MM games .015 to .04 on 3mill.Then down on measly 300k which a third were buys mon and tue.Today nice buying.Recieved email from Pawson yesterday.I have to give him a time to call me.We are giong to talk about the short situation in cal-bay.Back to you after I speak with him.

Thanks bro,we need to find us a couple retired mm's to make life a little easier.Later

Question guys:I know all the games the mm's play.Do you think their is any truth to the statements you see that they trade signals with share amounts traded ex.150-800 and on and on.I am an experienced investor but never actually new a market maker to verify this.If it was true wouldnt it be nice to know what those codes meant.Thanks Bob

Watch posod.Possible low float runner like goam-icge-rco.Appears to have bottomed.Later Bob

Hey Dee,cbyi just as I thought yesterday some shorties gettin scared.News will be out in near future as email from Pawson.Mainly all buys again today.Hoping for mother of all short squeezes when news hits with our low float.I have this gut feeling Pawson is going to do something to make these mm and possibly berlin shorts have to cover.Like what he has done in the past.http://www.nasdaqtrader.com/aspx/regsho.aspx
Talk to you later

Thanks teapee eom.

Dee,Recieved email back from pawson.To make a long story short,pr due out in week or so that in in his sincere opinion will be good for us shareholders outlining any concerns about the changeover.I threw every relevant question at him and am satisfied based on his past performance.Since I do not see cbyi mentioned anywhere today buying most likely as I thought either insiders or those nasty mm/naked shorters covering.We shall see soon enough.Bob

Dee,Looking around other boards,not seeing any news or pumping going on.Most likely new management taking positions.Also they were listed on berlin exchange so could be naked shorts/mm covering.I believe their will be a name change and these shorts may have to cover to show actual ownership.Correct me if I am wrong.